COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1458: Articles 14571-14580  | Next

Impacts of school closure due to COVID-19 on the mobility trend of Japanese citizens
Nam, N. H., Nguyen, A. P., Le, B.-T. D., Gad, A. G., Abdalla, A. S. M. A., Safi, A., Pham, A. G., Khanh, V. D., Huy, N. T.
10.1101/2021.06.30.21259816 — Posted: 2021-07-06
Increased frequency of recurrent in-frame deletions in new expanding lineages of SARS CoV-2 reflects immune selective pressure
Alisoltani, A., Jaroszewski, L., Iyer, M., Iranzadeh, A., Godzik, A.
10.1101/2021.07.04.451027 — Posted: 2021-07-06
Increased Histone-DNA Complexes and Endothelial-Dependent Thrombin Generation in Severe COVID-19
Bouchard, B. A., Colovos, C., Lawson, M., Sackhiem, A., Mould, K. J., Janssen, W. J., Cohen, M. J., Majumdar, D., Freeman, K.
10.1101/2021.07.03.450992 — Posted: 2021-07-05
Construction of a new chromosome-scale, long-read reference genome assembly of the Syrian hamster, Mesocricetus auratus
Harris, R. A., Raveendran, M., Lyfoung, D. T., Sedlazeck, F. J., Mahmoud, M., Prall, T., Karl, J., Doddapaneni, H., Meng, Q., Han, Y., Muzny, D., Wiseman, R. W., O'Connor, D. H., Rogers, J.
10.1101/2021.07.05.451071 — Posted: 2021-07-05
Mutation signatures inform the natural host of SARS-CoV-2
He, X.
10.1101/2021.07.05.451089 — Posted: 2021-07-05
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
Li, L., Honda-Okubo, Y., Huang, Y., Jang, H., Carlock, M. A., Baldwin, J., Piplani, S., Bebin-Blackwell, A. G., Forgacs, D., Sakamoto, K., Stella, A., Turville, S., Chataway, T., Colella, A., Triccas, J., Ross, T., Petrovsky, N.
10.1101/2021.07.03.451026 — Posted: 2021-07-05
Predicted Impact of the Viral Mutational Landscape on the Cytotoxic Response against SARS-CoV-2
Foix, A., Lopez, D., McConnell, M. J., Martin-Galiano, A. J.
10.1101/2021.07.04.451040 — Posted: 2021-07-05
Dynamics of SARS-CoV-2 host cell interactions inferred from transcriptome analyses
Adam, L., Stanifer, M., Springer, F., Mathony, J., Di Ponzio, C., Eils, R., Boulant, S., Niopek, D., Kallenberger, S. M.
10.1101/2021.07.04.450986 — Posted: 2021-07-05
A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
Gorshkov, K., Vasquez, D. M., Chiem, K., Ye, C., Nguyen Tran, B., de la Torre, J. C., Moran, T., Chen, C. Z., Martinez-Sobrido, L., Zheng, W.
10.1101/2021.07.03.450938 — Posted: 2021-07-05
A cGAMP-containing hydrogel for prolonged SARS-CoV-2 RBD subunit vaccine exposure induces a broad and potent humoral response
Gale, E. C., Lahey, L. J., Böhnert, V., Powell, A. E., Ou, B. S., Carozza, J. A., Li, L., Appel, E.
10.1101/2021.07.03.451025 — Posted: 2021-07-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).